Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy

doi:10.5500/wjt.v4.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9138)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

562

WORD

291

HTML

5239

Figures (1-6)

235

Tables (1-2)

218

Sum=6545

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1462

Download

1131

Sum=2593

Mar 24, 2014 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Transplant. Mar 24, 2014; 4(1): 1-17
Published online Mar 24, 2014. doi: 10.5500/wjt.v4.i1.1

Full Size Figure Download Figure

Figure 4 Deterioration of kidney allograft function study. Graft survival at 2-year according presence of donor-specific-HLA antibodies (DSAs) and/or C4d. HLA: Human leukocyte antigens.

Citation: Salvadori M, Bertoni E. Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy. World J Transplant 2014; 4(1): 1-17
URL: https://www.wjgnet.com/2220-3230/full/v4/i1/1.htm
DOI: https://dx.doi.org/10.5500/wjt.v4.i1.1